Product Catalog [{"id":"383","name":"Retsevmo","price":1231.88,"sku":"Retsevmo (selpercatinib)","brand":"Lilly, Loxo Oncology","position":10,"category":"Medicines\/Oncology\/Lung Cancer"},{"id":"353","name":"Tabrecta","price":17005.3,"sku":"Tabrecta (capmatinib)","brand":"Novartis Pharmaceuticals Corporation","position":11,"category":"Medicines\/Oncology\/Lung Cancer"},{"id":"351","name":"Zepzelca","price":12146.02,"sku":"Zepzelca (lurbinectedin)","brand":"Jazz Pharmaceuticals","position":12,"category":"Medicines\/Oncology\/Lung Cancer"},{"id":"347","name":"Enhertu","price":5165.1,"sku":"Enhertu-fam-trastuzumab deruxtecan-nxki","brand":"AstraZeneca Pharmaceuticals LP, Daiichi Sankyo Company Limited","position":13,"category":"Medicines\/Oncology\/Lung Cancer"},{"id":"270","name":"Libtayo","price":8328,"sku":"Libtayo (cemiplimab)","brand":"Sanofi","position":14,"category":"Medicines\/Oncology\/Lung Cancer"},{"id":"248","name":"Lorviqua","price":4656.03,"sku":"Lorviqua (lorlatinib)","brand":"Pfizer Limited","position":15,"category":"Medicines\/Oncology\/Lung Cancer"},{"id":"241","name":"Vizimpro","price":3120,"sku":"Vizimpro (dacomitinib)","brand":"Pfizer Limited","position":16,"category":"Medicines\/Oncology\/Lung Cancer"},{"id":"121","name":"Afinitor","price":1,"sku":"Afinitor (everolimus)","brand":"Novartis","position":17,"category":"Medicines\/Oncology\/Lung Cancer"},{"id":"64","name":"Cyramza","price":640.06,"sku":"Cyramza (ramucirumab)","brand":"Lilly","position":18,"category":"Medicines\/Oncology\/Lung Cancer"}]
Call our support: +31 20 8084 414
Google Reviews
4.8
Toggle Nav
Search
Advanced Search
You are reading an automatically translated version of our website that may contain translation errors.
Change to English
Menu
Account

TOMORROW'S MEDICINES TODAY

Lung Cancer access options

Lung cancer, also known as lung carcinoma, is characterised by uncontrolled cell growth in tissues of the lung. The two main types are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancers. With an incidence of 1.8 million, lung cancer was the most common cancer worldwide in 2012, contributing 13% of the total number of new cases diagnosed. Treatment and long-term outcomes depend on the type of lung cancer, the stage (degree of spread), and the person’s overall health. Common lung cancer treatments include surgery, chemotherapy, and radiotherapy. NSCLC is sometimes treated with surgery,... Read more » whereas SCLC usually responds better to chemotherapy and radiotherapy.
  1. Zepzelca
    Zepzelca (lurbinectedin)
    Lung Cancer
    €12,146.02
  2. Tabrecta
    Tabrecta (capmatinib)
    Lung Cancer
    €17,005.30
  3. Gavreto
    Gavreto (pralsetinib)
    Lung Cancer, Thyroid Cancer
    €11,157.08
  4. Cosela
    Cosela (trilaciclib)
    Lung Cancer
    €2,581.69
  5. Xalkori
    Xalkori (crizotinib)
    Lung Cancer, Lymphoma
    €4,927.62
  6. Rybrevant
    Rybrevant (amivantamab-vmjw)
    Lung Cancer
    €2,230.41
  7. Exkivity
    Exkivity (mobocertinib)
    Lung Cancer
    €30,225.00
  8. Vegzelma
    Vegzelma (bevacizumab-adcd)
    Colorectal Cancer, Gynaecological Cancer, Kidney Cancer, Liver Cancer, Lung Cancer
    €769.57
  9. Krazati
    Krazati (adagrasib)
    Lung Cancer
    Price available on request
  10. Augtyro
    Augtyro (repotrectinib)
    Lung Cancer
  11. Imfinzi
    Imfinzi (durvalumab)
    Urothelial Carcinoma, Lung Cancer
    €1,052.33
  12. Lumakras
    Lumakras (sotorasib)
    Lung Cancer
    €12,392.91
View as Grid List

Items 13-24 of 26

Set Descending Direction
Read more about the latest treatments in Lung Cancer
Explore disease areas
US 0